Scaffold for tubular septal occluder device and techniques for attachment

• US 20080077180A1
• Filed: 09/26/2007
• Published: 03/27/2008
• Est. Priority Date: 09/26/2006
• Status: Abandoned Application

• Current Assignee: WL Gore and Associates Incorporated (W.L. Gore and Associates)
• Original Assignee: NMT Medical Incorporated
• Inventors: Kladakis, Stephanie, Marchesiello, David, Devellian, Carol
• Application Number:
  US11/904,137
• Publication Number:
  US 20080077180A1
• Time in Patent Office: Days
• US Class Current: 606/216
• CPC Class Codes: A61B 17/0057 Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable, resorptive for implantable prostheses A61F2210/0004
• CPC Class Codes: A61B 2017/00526 Methods of manufacturing
• CPC Class Codes: A61B 2017/00575 for closure at remote site, e.g. closing atrial septum defects
• CPC Class Codes: A61B 2017/00592 Elastic or resilient implements
• CPC Class Codes: A61B 2017/00597 Implements comprising a membrane
• CPC Class Codes: A61B 2017/00606 Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
• CPC Class Codes: A61B 2017/00619 Locking means for locking the implement in expanded state
• CPC Class Codes: A61B 2017/00893 pharmaceutically effective
• CPC Class Codes: A61B 2017/00986 Malecots, e.g. slotted tubes, of which the distal end is pulled to deflect side struts

Abstract

The present invention provides a device for occluding an anatomical aperture, such as an atrial septal defect (ASD) or a patent foramen ovale (PFO). The occluder includes two sides connected by a central tube. A tissue scaffold material is disposed on the occluder. The occluder is formed from a tube, which is cut to produce struts in each side. Upon the application of force, the struts deform into loops. The loops may be of various shapes, sizes, and configurations, and, in at least some embodiments, the loops have rounded peripheries. In some embodiments, at least one side of the occluder includes a tissue scaffold. The occluder further includes a catch system that maintains its deployed state in vivo. When the occluder is deployed in vivo, the two sides are disposed on opposite sides of the septal tissue surrounding the aperture and the catch system is deployed so that the occluder exerts a compressive force on the septal tissue and closes the aperture.

Claims

1. An occluder, comprising:

a first anchor member for deployment proximate a first end of a septal defect;

a second anchor member for deployment proximate a second end of said septal defect wherein at least one of the first and second anchor members includes radially expandable struts;

a connecting member connecting said first and second anchor members; and

a tissue scaffold attached to at least one of the radially expandable struts of the anchor members that improves the sealing between the occluder and the defect.

2. The occluder of claim 1, wherein said first and second anchor members and said connecting member comprise bioresorbable materials.

3. The occluder of claim 1 wherein a tissue scaffold is disposed on each of the first and second anchor members.

4. The occluder of claim 3 wherein a side of each of the first and second anchor members includes a tissue scaffold.

5. The occluder of claim 4 wherein a disc is attached to each side of the each of the first and second anchor members.

6. The occluder of claim 1 wherein the tissue scaffold is attached to an outer surface of the connecting member.

7. The occluder of claim 1 wherein the tissue scaffold includes a disc shaped material comprising an outer edge, wherein the outer edge of the disc shaped material is non-circular.

24. The occluder of claim 1 wherein tissue scaffolding is attached to the outer surface of the connecting member.

8. A septal defect closure device for closing a defect in heart tissue, comprising:

a first anchor member having a generally cylindrical tubular shape for deployment proximate a first end of a septal defect and an expanded shape for apposition against tissue;

a second anchor member having a generally cylindrical tubular shape for deployment proximate a second end of said septal defect and an expanded shape for apposition against tissue;

a connector member joining the first anchor member and second anchor member; and

a tissue scaffolding surrounding a substantial portion of the occluder.

9. The device of claim 8 wherein the tissue scaffolding includes a pharmacological agent for producing a desired physiological result.

10. The device of claim 8 wherein the tissue scaffolding includes at least two discs used to cover one of the first and second anchor members, wherein one disc is sized larger than the other.

11. The device of claim 10 wherein said one disc has a diameter that is 110% larger than the smaller disc.

12. The device of claim 11 wherein each disc comprises an outer edge, wherein the outer edge of one disc is folded over the outer edge of the other disc.

13. A septal defect closure device having a generally tubular delivery configuration and an expanded diameter deployed configuration, comprising:

an elongated proximal anchor member for deployment proximate a first end of a septal defect;

an elongated distal anchor member for deployment proximate a second end of said septal defect;

a connector member joining the proximal and distal anchor members; and

,

a tissue scaffold attached to the septal defect closure device and configured to be disposed between the septal defect and the septal defect closure device.

14. The device of claim 13 wherein the tissue scaffold comprises a thrombogenic or inflammatory material.

15. The device of claim 14 wherein the tissue scaffold further comprises a bioabsorbable material.

16. The device of claim 14 wherein the tissue scaffold further comprises a biological material.

17. The device of claim 16 wherein the biological material comprises a purified bioengineered type I collagen.

18. The occluder of claim 17, wherein the purified bioengineered type I collagen is derived from a tunica submucosa layer of a porcine small intestine.

19. The device of claim 14 wherein said tissue scaffold is covered with a growth factor to accelerate tissue ingrowth.

20. A septal defect occluder, comprising:

a proximal anchor member for deployment proximate a first end of a septal defect;

a distal anchor member for deployment proximate a second end of said septal defect;

a flexible connector member connecting said proximal and distal anchor members; and

a tissue scaffolding formed from a plurality of discs affixed to at least one of the proximal and distal anchor members.

21. The occluder of claim 20 wherein said proximal and distal anchor members and said connection member comprise bioresorbable materials.

22. The occluder of claim 21 wherein a tissue scaffold is disposed on each of the proximal and distal anchor members.

23. The occluder of claim 21 wherein a side of each anchor member for contacting a tissue surface includes a tissue scaffold.

25. The method of attaching tissue scaffold to an occluder including the steps of:

a) cutting a first piece of scaffold material,

b) placing the first piece of scaffold material at the desired attachment location

c) melting the first piece of scaffold to the occluder,

d) cutting a second piece of scaffold material,

e) placing the second piece of scaffold material proximate to the first piece of scaffold material, and

f) melting the edge of the first piece of scaffold material to the edge of the second piece of scaffold material.